Inventor

Maxim Totrov

Inventor
San Diego, CA, US

Overview

20→
Patents
2013–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
Y02ATechnologies for adaptation to climate change22%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium21%
C07KPeptides4%
C12NMicroorganisms or enzymes4%
C07DHeterocyclic compounds1%
PatentTitleYear
11,090,319Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives202110,639,318Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives202010,568,969Immunogenic polypeptides202010,206,937Boronic acid derivatives and therapeutic uses thereof201910,183,034Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives201910,172,874Pharmaceutical compositions comprising cyclic boronic acid ester derivatives201910,004,758Cyclic boronic acid ester derivatives and methods of making the same20189,963,467Boronic acid derivatives and therapeutic uses thereof20189,694,025'Cyclic boronic acid ester derivatives and therapeutic uses thereof'20179,642,869'Boronic acid derivatives and therapeutic uses thereof'20179,534,020'Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide'20179,296,763'Cyclic boronic acid ester derivatives and therapeutic uses thereof'20169,241,947'Boronic acid derivatives and therapeutic uses thereof'20169,156,858'Boronic acid derivatives and therapeutic uses thereof'20159,132,140'Boronic acid derivatives and therapeutic uses thereof'20159,101,638'Boronic acid derivatives and therapeutic uses thereof'20159,012,491'Heterocyclic boronic acid ester derivatives and therapeutic uses thereof'20158,961,987'Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies'20158,680,136'Cyclic boronic acid ester derivatives and therapeutic uses thereof'20148,394,811'Hydrazide compounds as thyroid hormone receptor modulators and uses thereof'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2017Patents assigned to TOTROV MAXIM (5)· patent assignee history
2013–2020Patents assigned to MOLSOFT LLC (4)· patent assignee history
2013–2015Patents assigned to ABAGYAN RUBEN (2)· patent assignee history
2013–2021Based in San Diego, CA, US· patent location history
2014–2020Patents assigned to REMPEX PHARMACEUTICALS INC (14)· patent assignee history
2014–2015Based in San Bernardino, CA, US· patent location history
2015–2020Patents assigned to UNIV NEW YORK (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REMPEX PHARMACEUTICALS INC142014–2020
TOTROV MAXIMself52013–2017
MOLSOFT LLC42013–2020
UNIV NEW YORK32015–2020
ABAGYAN RUBEN22013–2015
Locations
LocationPatentsSpan
San Diego, California, US182013–2021
San Bernardino, California, US22014–2015